BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671-680. [PMID: 8899074 DOI: 10.1046/j.1365-2036.1996.66237000.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Soderquist CR, Bhagat G. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders. Seminars in Diagnostic Pathology 2020;37:11-23. [DOI: 10.1053/j.semdp.2019.08.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
2 Tennyson CA, Semrad CE. Small bowel imaging in celiac disease. Gastrointest Endosc Clin N Am 2012;22:735-46. [PMID: 23083990 DOI: 10.1016/j.giec.2012.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Gładyś K, Dardzińska J, Guzek M, Adrych K, Małgorzewicz S. Celiac Dietary Adherence Test and Standardized Dietician Evaluation in Assessment of Adherence to a Gluten-Free Diet in Patients with Celiac Disease. Nutrients 2020;12:E2300. [PMID: 32751809 DOI: 10.3390/nu12082300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kwon JH, Farrell RJ. Recent Advances in the Understanding of Celiac Disease: Therapeutic Implications for the Management of Pediatric Patients. Pediatric Drugs 2006;8:375-88. [DOI: 10.2165/00148581-200608060-00005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000;119:243-51. [PMID: 10889175 DOI: 10.1053/gast.2000.8530] [Cited by in Crossref: 105] [Cited by in F6Publishing: 84] [Article Influence: 4.8] [Reference Citation Analysis]
6 Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B, Macintyre E, Cerf-bensussan N, Brousse N. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. The Lancet 2000;356:203-8. [DOI: 10.1016/s0140-6736(00)02481-8] [Cited by in Crossref: 481] [Cited by in F6Publishing: 107] [Article Influence: 21.9] [Reference Citation Analysis]
7 Galli G, Carabotti M, Pilozzi E, Lahner E, Annibale B, Conti L. Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients. Nutrients 2021;13:600. [PMID: 33673062 DOI: 10.3390/nu13020600] [Reference Citation Analysis]
8 Rishi AR, Rubio-Tapia A, Murray JA. Refractory celiac disease. Expert Rev Gastroenterol Hepatol 2016;10:537-46. [PMID: 26603931 DOI: 10.1586/17474124.2016.1124759] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
9 Gillett HR, Arnott ID, McIntyre M, Campbell S, Dahele A, Priest M, Jackson R, Ghosh S. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002;122:800-5. [PMID: 11875014 DOI: 10.1053/gast.2002.31874] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.3] [Reference Citation Analysis]
10 Leffler DA, Dennis M, Edwards George JB, Jamma S, Magge S, Cook EF, Schuppan D, Kelly CP. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 2009; 7: 530-536, 536.e1-536. e2. [PMID: 19268725 DOI: 10.1016/j.cgh.2008.12.032] [Cited by in Crossref: 135] [Cited by in F6Publishing: 138] [Article Influence: 10.4] [Reference Citation Analysis]
11 Rej A, Aziz I, Sanders DS. Coeliac disease and noncoeliac wheat or gluten sensitivity. J Intern Med 2020;288:537-49. [PMID: 32573000 DOI: 10.1111/joim.13120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Abdallah H, Leffler D, Dennis M, Kelly CP. Refractory celiac disease. Curr Gastroenterol Rep 2007;9:401-5. [PMID: 17991341 DOI: 10.1007/s11894-007-0049-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
13 Ilus T, Kaukinen K, Virta LJ, Huhtala H, Mäki M, Kurppa K, Heikkinen M, Heikura M, Hirsi E, Jantunen K, Moilanen V, Nielsen C, Puhto M, Pölkki H, Vihriälä I, Collin P. Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease. Aliment Pharmacol Ther 2014;39:418-25. [DOI: 10.1111/apt.12606] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
14 Abbas A, Shahab T, Sherwani RK, Alam S. Addition of a Short Course of Prednisolone to a Gluten-Free Diet vs. Gluten-Free Diet Alone in Recovery of Celiac Disease: A Pilot Randomized Controlled Trial. Cureus 2018;10:e2118. [PMID: 29600122 DOI: 10.7759/cureus.2118] [Reference Citation Analysis]
15 Sategna Guidetti C, Scaglione N, Martini S. Red cell distribution width as a marker of coeliac disease: a prospective study. Eur J Gastroenterol Hepatol. 2002;14:177-181. [PMID: 11981342 DOI: 10.1097/00042737-200202000-00012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
16 Seven G, Assaad A, Biehl T, Kozarek RA. Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis. World J Gastroenterol 2012; 18(36): 5135-5137 [PMID: 23049226 DOI: 10.3748/wjg.v18.i36.5135] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Medlicott SAC, Coderre S, Horne G, Panaccione R. Multimodal Immunosuppressant Therapy in Steroid-Refractory Common Variable Immunodeficiency Sprue: A Case Report Complicating Cytomegalovirus Infection. Int J Surg Pathol 2006;14:101-6. [DOI: 10.1177/106689690601400120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
18 Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011;8:405-415. [PMID: 21629239 DOI: 10.1038/nrgastro.2011.91] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
19 Mulder CJ, Wahab PJ, Meijer JW, Metselaar E. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol. 2001;13:1183-1188. [PMID: 11711774 DOI: 10.1097/00042737-200110000-00010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
20 Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007;56:1373-8. [PMID: 17470479 DOI: 10.1136/gut.2006.114512] [Cited by in Crossref: 199] [Cited by in F6Publishing: 174] [Article Influence: 13.3] [Reference Citation Analysis]
21 Giorgetti GM, Tursi A, Iani C, Arciprete F, Brandimarte G, Capria A, Fontana L. Assessment of autonomic function in untreated adult coeliac disease. World J Gastroenterol 2004; 10(18): 2715-2718 [PMID: 15309725 DOI: 10.3748/wjg.v10.i18.2715] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
22 United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol. 2001;13:1123-1128. [PMID: 11564968 DOI: 10.1097/00042737-200109000-00023] [Cited by in Crossref: 92] [Cited by in F6Publishing: 102] [Article Influence: 4.4] [Reference Citation Analysis]
23 Jacobsson LR, Milberg A, Hjelm K, Friedrichsen M. Experiences and own management regarding residual symptoms among people with coeliac disease. Appl Nurs Res 2017;35:53-8. [PMID: 28532727 DOI: 10.1016/j.apnr.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Stasi E, Marafini I, Caruso R, Soderino F, Angelucci E, Del Vecchio Blanco G, Paoluzi OA, Calabrese E, Sedda S, Zorzi F, Pallone F, Monteleone G. Frequency and Cause of Persistent Symptoms in Celiac Disease Patients on a Long-term Gluten-free Diet. Journal of Clinical Gastroenterology 2016;50:239-43. [DOI: 10.1097/mcg.0000000000000392] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
25 Mubarak A, Wolters VM, Houwen RH, ten Kate FJ. Immunohistochemical CD3 staining detects additional patients with celiac disease. World J Gastroenterol 2015; 21(24): 7553-7557 [PMID: 26140002 DOI: 10.3748/wjg.v21.i24.7553] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
26 Kaukinen K, Halme L, Collin P, Färkkilä M, Mäki M, Vehmanen P, Partanen J, Höckerstedt K. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122:881-888. [PMID: 11910339 DOI: 10.1053/gast.2002.32416] [Cited by in Crossref: 177] [Cited by in F6Publishing: 148] [Article Influence: 8.9] [Reference Citation Analysis]
27 Evans KE, Leeds JS, Morley S, Sanders DS. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci. 2010;55:2999-3004. [PMID: 20458623 DOI: 10.1007/s10620-010-1261-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
28 Reilly NR, Husby S, Sanders DS, Green PHR. Coeliac disease: to biopsy or not? Nat Rev Gastroenterol Hepatol 2018;15:60-6. [PMID: 29018278 DOI: 10.1038/nrgastro.2017.121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
29 van Gerven NM, Bakker SF, de Boer YS, Witte BI, Bontkes H, van Nieuwkerk CM, Mulder CJ, Bouma G. Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2014;26:1104-1107. [PMID: 25089548 DOI: 10.1097/meg.0000000000000172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
30 Kurien M, Evans KE, Aziz I, Sidhu R, Drew K, Rogers TL, McAlindon ME, Sanders DS. Capsule endoscopy in adult celiac disease: a potential role in equivocal cases of celiac disease? Gastrointest Endosc. 2013;77:227-232. [PMID: 23200728 DOI: 10.1016/j.gie.2012.09.031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
31 Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol. 2001;13:561-565. [PMID: 11396537 DOI: 10.1097/00042737-200105000-00016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.4] [Reference Citation Analysis]
32 Chander U, Leeman-Neill RJ, Bhagat G. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Curr Hematol Malig Rep. 2018;13:308-317. [PMID: 29943210 DOI: 10.1007/s11899-018-0459-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
33 van Wanrooij RL, Bouma G, Bontkes HJ, Neefjes-Borst A, van Grieken NC, von Blomberg BM, Mulder CJ. Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands. Clin Transl Gastroenterol 2017;8:e218. [PMID: 28125074 DOI: 10.1038/ctg.2016.70] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
34 Kennedy NP, Feighery C. Clinical features of coeliac disease today. Biomed Pharmacother. 2000;54:373-380. [PMID: 10989976 DOI: 10.1016/s0753-3322(01)80004-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
35 Green PH, Yang J, Cheng J, Lee AR, Harper JW, Bhagat G. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol 2009;7:1210-6. [PMID: 19631283 DOI: 10.1016/j.cgh.2009.07.011] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
36 Tennyson CA, Simpson S, Lebwohl B, Lewis S, Green PH. Interest in medical therapy for celiac disease. Therap Adv Gastroenterol 2013;6:358-64. [PMID: 24003336 DOI: 10.1177/1756283X13492580] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
37 Fernandes A, Ferreira AM, Ferreira R, Mendes S, Agostinho C, Almeida N, Figueiredo P, Ferreira M, Amaro P, Castro LPE, Sofia C. Refractory Celiac Disease Type II: A Case Report that Demonstrates the Diagnostic and Therapeutic Challenges. GE Port J Gastroenterol 2016;23:106-12. [PMID: 28868442 DOI: 10.1016/j.jpge.2015.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839-843. [PMID: 12738465 DOI: 10.1111/j.1572-0241.2003.07379.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
39 Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001;120:636-651. [PMID: 11179241 DOI: 10.1053/gast.2001.22123] [Cited by in Crossref: 764] [Cited by in F6Publishing: 643] [Article Influence: 36.4] [Reference Citation Analysis]
40 Soderquist CR, Bhagat G. Cellular and molecular bases of refractory celiac disease. Int Rev Cell Mol Biol 2021;358:207-40. [PMID: 33707055 DOI: 10.1016/bs.ircmb.2020.12.001] [Reference Citation Analysis]
41 Al-bawardy B, Codipilly DC, Rubio-tapia A, Bruining DH, Hansel SL, Murray JA. Celiac disease: a clinical review. Abdom Radiol 2017;42:351-60. [DOI: 10.1007/s00261-016-1034-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
42 Green PH, Lebwohl B. Mesalamine for Refractory Celiac Disease: An Old Medicine for a New Disease. Journal of Clinical Gastroenterology 2011;45:1-3. [DOI: 10.1097/mcg.0b013e3181fb4535] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 Sigman T, Nguyen VH, Costea F, Sant'Anna A, Seidman EG. Ulcerative jejunitis in a child with celiac disease. BMC Gastroenterol 2014;14:29. [PMID: 24524552 DOI: 10.1186/1471-230X-14-29] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
44 Nehra V. NEW CLINICAL ISSUES IN CELIAC DISEASE. Gastroenterology Clinics of North America 1998;27:453-65. [DOI: 10.1016/s0889-8553(05)70013-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Mubarak A, Oudshoorn JH, Kneepkens CM, Butler JC, Schreurs MW, Mulder CJ, Houwen RH. A child with refractory coeliac disease. J Pediatr Gastroenterol Nutr 2011;53:216-8. [PMID: 21788766 DOI: 10.1097/MPG.0b013e318214553a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
46 Cichewicz AB, Mearns ES, Taylor A, Boulanger T, Gerber M, Leffler DA, Drahos J, Sanders DS, Thomas Craig KJ, Lebwohl B. Diagnosis and Treatment Patterns in Celiac Disease. Dig Dis Sci. 2019;. [PMID: 30820708 DOI: 10.1007/s10620-019-05528-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
47 Baggus EMR, Hadjivassiliou M, Cross S, Penny H, Urwin H, Watson S, Woodward JM, Sanders DS. How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.Frontline Gastroenterol. 2020;11:235-242. [PMID: 32419915 DOI: 10.1136/flgastro-2019-101191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
48 Tursi A, Brandimarte G, Giorgetti G. Sorbitol H2-breath test versus anti-endomysium antibodies to assess histological recovery after gluten-free diet in coeliac disease. Digestive and Liver Disease 2002;34:846-50. [DOI: 10.1016/s1590-8658(02)80254-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Chetcuti Zammit S, Kurien M, Sanders D, Sidhu R. What is the role of small bowel capsule endoscopy in established coeliac disease? Clinics and Research in Hepatology and Gastroenterology 2020;44:753-61. [DOI: 10.1016/j.clinre.2019.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Tovoli F, Granito A, Negrini G, Guidetti E, Faggiano C, Bolondi L. Long term effects of gluten-free diet in non-celiac wheat sensitivity. Clinical Nutrition 2019;38:357-63. [DOI: 10.1016/j.clnu.2017.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
51 Tursi A, Brandimarte G, Giorgetti GM. Lack of Usefulness of Anti-Transglutaminase Antibodies in Assessing Histologic Recovery After Gluten-Free Diet in Celiac Disease: . Journal of Clinical Gastroenterology 2003;37:387-91. [DOI: 10.1097/00004836-200311000-00007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
52 Evans KE, Sanders DS. Celiac disease. Gastroenterol Clin North Am 2012;41:639-50. [PMID: 22917169 DOI: 10.1016/j.gtc.2012.06.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
53 Kaukinen K, Peräaho M, Lindfors K, Partanen J, Woolley N, Pikkarainen P, Karvonen AL, Laasanen T, Sievänen H, Mäki M, Collin P. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther 2007;25:1237-45. [PMID: 17451570 DOI: 10.1111/j.1365-2036.2007.03311.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 6.7] [Reference Citation Analysis]
54 Parnell, Ciclitira. Review article: coeliac disease and its management: REVIEW: COELIAC DISEASE. Alimentary Pharmacology & Therapeutics 1999;13:1-13. [DOI: 10.1046/j.1365-2036.1999.00448.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
55 Goerres MS, Meijer JW, Wahab PJ, Kerckhaert JA, Groenen PJ, Van Krieken JH, Mulder CJ. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther. 2003;18:487-494. [PMID: 12950421 DOI: 10.1046/j.1365-2036.2003.01687.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 5.2] [Reference Citation Analysis]
56 Maiden L, Elliott T, McLaughlin SD, Ciclitira P. A blinded pilot comparison of capsule endoscopy and small bowel histology in unresponsive celiac disease. Dig Dis Sci. 2009;54:1280-1283. [PMID: 18975089 DOI: 10.1007/s10620-008-0486-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
57 Canestaro WJ, Edwards TC, Patrick DL. Systematic review: patient-reported outcome measures in coeliac disease for regulatory submissions. Aliment Pharmacol Ther 2016;44:313-31. [DOI: 10.1111/apt.13703] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
58 Penny HA, Baggus EMR, Rej A, Snowden JA, Sanders DS. Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease. Nutrients 2020;12:E216. [PMID: 31947666 DOI: 10.3390/nu12010216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
59 Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016-2021. [PMID: 12190170 DOI: 10.1111/j.1572-0241.2002.05917.x] [Cited by in Crossref: 200] [Cited by in F6Publishing: 182] [Article Influence: 10.0] [Reference Citation Analysis]
60 Nion-Larmurier I, Cosnes J. [Celiac disease]. Gastroenterol Clin Biol 2009;33:508-17. [PMID: 19304426 DOI: 10.1016/j.gcb.2009.02.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Tennyson CA, Ciaccio EJ, Lewis SK. Video capsule endoscopy in celiac disease. Gastrointest Endosc Clin N Am. 2012;22:747-758. [PMID: 23083991 DOI: 10.1016/j.giec.2012.07.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
62 Biagi F, Bianchi PI, Marchese A, Trotta L, Vattiato C, Balduzzi D, Brusco G, Andrealli A, Cisarò F, Astegiano M, Pellegrino S, Magazzù G, Klersy C, Corazza GR. A score that verifies adherence to a gluten-free diet: a cross-sectional, multicentre validation in real clinical life. Br J Nutr 2012;108:1884-8. [PMID: 22321199 DOI: 10.1017/S0007114511007367] [Cited by in Crossref: 63] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
63 Abdulkarim AS, Murray JA. Celiac disease. Curr Treat Options Gastro 2002;5:27-38. [DOI: 10.1007/s11938-002-0004-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
64 Pietzak MM, Catassi C, Drago S, Fornaroli F, Fasano A. Celiac Disease: Going Against the Grains. Nutr Clin Pract 2016;16:335-44. [DOI: 10.1177/088453360101600606] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
65 Durie P, Baillargeon JD, Bouchard S, Donnellan F, Zepeda-Gomez S, Teshima C. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel. Curr Med Res Opin 2018;34:25-33. [PMID: 28985688 DOI: 10.1080/03007995.2017.1389704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
66 Mauriño E, Niveloni S, Cherñavsky A, Pedreira S, Mazure R, Vazquez H, Reyes H, Fiorini A, Smecuol E, Cabanne A, Capucchio M, Kogan Z, Bai JC. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002;97:2595-602. [PMID: 12385445 DOI: 10.1111/j.1572-0241.2002.06029.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
67 Woodward J. The management of refractory coeliac disease. Ther Adv Chronic Dis 2013;4:77-90. [PMID: 23556127 DOI: 10.1177/2040622312473174] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
68 Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-76; quiz 677. [PMID: 23609613 DOI: 10.1038/ajg.2013.79] [Cited by in Crossref: 878] [Cited by in F6Publishing: 712] [Article Influence: 97.6] [Reference Citation Analysis]
69 Tennyson CA, Lewis SK, Green PH. New and developing therapies for celiac disease. Therap Adv Gastroenterol 2009;2:303-9. [PMID: 21180558 DOI: 10.1177/1756283X09342759] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
70 Chang MS, Minaya MT, Cheng J, Connor BA, Lewis SK, Green PH. Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease. Dig Dis Sci 2011;56:2939-46. [PMID: 21647654 DOI: 10.1007/s10620-011-1719-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
71 Mino-kenudson M, Brown I, Lauwers G. Histopathological diagnosis of gluten-sensitive enteropathy. Current Diagnostic Pathology 2005;11:274-83. [DOI: 10.1016/j.cdip.2005.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
72 Odetti P, Valentini S, Aragno I, Garibaldi S, Pronzato MA, Rolandi E, Barreca T. Oxidative stress in subjects affected by celiac disease. Free Radic Res. 1998;29:17-24. [PMID: 9733018 DOI: 10.1080/10715769800300031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
73 Wahab PJ, Crusius JB, Meijer JW, Uil JJ, Mulder CJ. Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study. Aliment Pharmacol Ther. 2000;14:767-774. [PMID: 10848661 DOI: 10.1046/j.1365-2036.2000.00718.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 2.5] [Reference Citation Analysis]
74 Jassim SH, Smith LB. New/Revised Entities in Gastrointestinal Lymphoproliferative Disorders. Surg Pathol Clin 2019;12:733-43. [PMID: 31352985 DOI: 10.1016/j.path.2019.03.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Veeraraghavan G, Therrien A, Degroote M, McKeown A, Mitchell PD, Silvester JA, Leffler DA, Leichtner AM, Kelly CP, Weir DC. Non-responsive celiac disease in children on a gluten free diet. World J Gastroenterol 2021; 27(13): 1311-1320 [PMID: 33833484 DOI: 10.3748/wjg.v27.i13.1311] [Reference Citation Analysis]
76 Evans KE, Sanders DS. Symposium 1: Joint BAPEN and British Society of Gastroenterology Symposium on ‘Coeliac disease: basics and controversies’ Coeliac disease: optimising the management of patients with persisting symptoms?: Conference on ‘Malnutrition matters’. Proc Nutr Soc 2009;68:242-8. [DOI: 10.1017/s0029665109001360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
77 Lanzini A, Lanzarotto F, Villanacci V, Mora A, Bertolazzi S, Turini D, Carella G, Malagoli A, Ferrante G, Cesana BM. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther. 2009;29:1299-1308. [PMID: 19302264 DOI: 10.1111/j.1365-2036.2009.03992.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 151] [Article Influence: 11.9] [Reference Citation Analysis]
78 Dewar DH, Donnelly SC, McLaughlin SD, Johnson MW, Ellis HJ, Ciclitira PJ. Celiac disease: Management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol 2012; 18(12): 1348-1356 [PMID: 22493548 DOI: 10.3748/wjg.v18.i12.1348] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 62] [Article Influence: 6.6] [Reference Citation Analysis]
79 Tlaskalová H, Tučková L, Pospišil M, Štěpánková R. Malignancy in Coeliac Disease and Dermatitis Herpetiformis. Cancer and Autoimmunity. Elsevier; 2000. pp. 105-10. [DOI: 10.1016/b978-044450331-2/50012-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
80 Chang MS, Green PH. A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease. Therap Adv Gastroenterol 2012;5:31-6. [PMID: 22282706 DOI: 10.1177/1756283X11422264] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
81 Tennyson CA, Green PH. The role of capsule endoscopy in patients with nonresponsive celiac disease. Gastrointest Endosc. 2011;74:1323-1324. [PMID: 22136777 DOI: 10.1016/j.gie.2011.07.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
82 Valitutti F, Trovato CM, Montuori M, Cucchiara S. Pediatric Celiac Disease: Follow-Up in the Spotlight. Adv Nutr. 2017;8:356-361. [PMID: 28298278 DOI: 10.3945/an.116.013292] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
83 Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, Verduijn W, Wijmenga C, Mulder CJ. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol. 2007;5:1399-1405, 1405.e1-2. [PMID: 17967566 DOI: 10.1016/j.cgh.2007.08.018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
84 Sanchez-Muñoz LB, Santón A, Cano A, Lopez A, Almeida J, Orfao A, Escribano L, Roy G. Flow cytometric analysis of intestinal intraepithelial lymphocytes in the diagnosis of refractory celiac sprue. Eur J Gastroenterol Hepatol 2008;20:478-87. [PMID: 18403953 DOI: 10.1097/MEG.0b013e3282f16a4b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
85 Leeds JS, Hopper AD, Hurlstone DP, Edwards SJ, McAlindon ME, Lobo AJ, Donnelly MT, Morley S, Sanders DS. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther. 2007;25:265-271. [PMID: 17269988 DOI: 10.1111/j.1365-2036.2006.03206.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
86 Panetta F, Nobili V, Sartorelli MR, Papa RE, Ferretti F, Alterio A, Diamanti A. Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs. 2012;14:35-41. [PMID: 22149550 DOI: 10.2165/11593150-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
87 Brar P, Lee S, Lewis S, Egbuna I, Bhagat G, Green PH. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol 2007;102:2265-9. [PMID: 17581265 DOI: 10.1111/j.1572-0241.2007.01380.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
88 Arguelles-Grande C, Brar P, Green PH, Bhagat G. Immunohistochemical and T-cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory celiac disease. J Clin Gastroenterol 2013;47:593-601. [PMID: 23470642 DOI: 10.1097/MCG.0b013e31828a3c44] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
89 Carbonnel F, Grollet-bioul L, Brouet JC, Teilhac MF, Cosnes J, Angonin R, Deschaseaux M, Châtelet F, Gendre JP, Sigaux F. Are Complicated Forms of Celiac Disease Cryptic T-Cell Lymphomas? Blood 1998;92:3879-86. [DOI: 10.1182/blood.v92.10.3879] [Cited by in Crossref: 102] [Article Influence: 4.3] [Reference Citation Analysis]
90 Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445-450. [PMID: 17382600 DOI: 10.1016/j.cgh.2006.12.006] [Cited by in Crossref: 195] [Cited by in F6Publishing: 175] [Article Influence: 13.0] [Reference Citation Analysis]
91 Lee J, Clarke K. Effect of clinical and laboratory parameters on quality of life in celiac patients using celiac disease-specific quality of life scores. Scand J Gastroenterol 2017;52:1235-9. [PMID: 28685635 DOI: 10.1080/00365521.2017.1350283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
92 Al Shammeri O, Duerksen DR. Celiac crisis in an adult on immunosuppressive therapy. Can J Gastroenterol. 2008;22:574-576. [PMID: 18560637 DOI: 10.1155/2008/453520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
93 O’shea U, Abuzakouk M, O’morain C, O’donoghue D, Sheahan K, Watson P, O’briain S, Alexander D, Catherwood M, Jackson J, Kelly J, Feighery C. Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort: Table 1. J Clin Pathol 2008;61:1200-2. [DOI: 10.1136/jcp.2008.058404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]